News and Trends 15 Jan 2018 The FDA Gives AstraZeneca’s Breast Cancer Drug the Go-Ahead The UK big pharma company’s Lynparza will be for women with advanced breast cancer that is specifically caused by mutations in the BRCA gene. Global pharma giant AstraZeneca focuses on the development of drugs for cancer, cardiovascular and respiratory diseases. The company, which is working on a number of small molecules and biologics for a […] January 15, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jan 2018 This is Why You Should Avoid Eating too Much Junk Food Following last week’s article about the importance of eating plenty of fruit and vegetables, German researchers have unearthed another link between junk food and diabetes and heart disease. Researchers from the University of Bonn, Germany, have found that an unhealthy diet can cause the immune system to act as if it is responding to bacterial […] January 15, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jan 2018 Mars Astronauts Might Wear Spacesuits Made of Fungi A team of biodesigners is getting us ready to live on Mars by creating the clothes that future Martians will use using fungi to create the materials. Science fiction has been preparing us for the colonization of Mars for over a century. Many see the planet as an alternative home for when we destroy or overcrowd […] January 13, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jan 2018 This Collaboration Will Develop a New Epilepsy Gene Therapy for In-Need Patients CombiGene and the Cell and Gene Therapy Catapult have struck a deal that will move the biotech’s epilepsy therapy towards the clinic. Swedish biotech CombiGene has combined neuroscience and advances in gene delivery to pioneer and new therapy for epilepsy that has brought down the number of seizures in preclinical studies. The company has joined forces […] January 12, 2018 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jan 2018 These Biomaterials Could Help to Make Stem Cell Therapies a Reality British researchers have developed biomaterials that better recreate the conditions required for stem cells to grow into desired cell types. Researchers at Imperial College London have used 3D printing to create biological structures that can support tissue regeneration. The study, published in Scientific Reports, outlines how the group used cryogenics – freezing – to create a biomaterial that mimics the […] January 12, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2018 German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study The FDA will allow Immunic Therapeutics to commence a Phase II clinical trial to test its oral investigational drug, IMU-838, for the treatment of ulcerative colitis. Immunic Therapeutics, which closed a €31M Series A last September, specializes in the development of drugs for the treatment of chronic inflammatory diseases. At the moment, the company has two ongoing […] January 11, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2018 Carbios’ Bioplastics Can Now Be Infinitely Recycled at Scale Scale-up is a major challenge in industrial biotech but Carbios has done it, going large-scale with its recyclable bioplastics technology. Carbios, a young and exciting green chemistry company, aims to find solutions to the environmental and sustainability issues faced by businesses. Since 2012, the company has been leading the THANAPLAST program, which has brought together academic and industrial […] January 11, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2018 Here’s Another Reason to Eat Plenty of Fruit and Vegetables Researchers have discovered that bacteria break down fruit and vegetables to produce chemicals that control our genes and could help to prevent cancer and fight infections. British scientists from the Babraham Institute in Cambridge, UK, with colleagues from Brazil and Italy, have discovered a mechanism by which helpful bacteria in the gut can control the […] January 11, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Inside Labiotech 11 Jan 2018 A Day In The Life of a Labiotech-er I read the news today oh boy… You read the articles, but what exactly goes on behind the scenes? Here’s a sneak preview of a day in the life of your favorite Labiotech team. 8:00 am: Evelyn, our Editor-in-Chief arrives. Why so early? Because she’s crazy. Also because the early bird gets the worm. 9-9:30 […] January 11, 2018 - 4 minutesmins - By Katherine Douglas Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jan 2018 New Venture Fund Closes $102M to Boost Biotech and Medical Device Development Truffle Capital has raised $102M (€85M), which will support biotechs, with a focus on medical device companies that have the potential to become market leaders. Truffle Capital, founded in 2001 and based in Paris, is a venture capital firm that focuses on supporting start-ups in life sciences and IT. The company manages assets worth over $1.1B […] January 10, 2018 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jan 2018 French Biotech Starts Trials to Restore Sight in All Types of Retinitis Pigmentosa GenSight will start a clinical trial in the UK testing a combination of gene therapy and a wearable device to restore sight in patients with retinitis pigmentosa. The UK Medicines and Healthcare Regulatory Agency (MHRA) has accepted GenSight’s application to run a first clinical trial in the UK testing a new type of therapy with the […] January 10, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 10 Jan 2018 These Dissolving Lenses Could Wash Away Glaucoma Patients’ Problems Students at the Kaunas University of Technology, Lithuania, are developing dissolving contact lenses, which could help individuals suffering from glaucoma. A team of students from Kaunas University of Technology (KTU) won second place at the Silicon Valley Innovation Challenge in the Best Global Innovation category for their NanoLens technology. Their idea is to produce contact lenses that contain […] January 10, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email